Dr. Quintana is a leader in the fields of immune regulation and neurodegeneration. Dr. Quintana’s research investigates signaling pathways that control the immune response and neurodegeneration, with the ultimate goal of identifying novel therapeutic targets and biomarkers for immune-mediated disorders. Dr. Quintana has published over 140 peer reviewed articles and book chapters. In addition, Dr. Quintana’s research has resulted in multiple patents which have been the foundation of three companies: ImmunArray Ltd, Alma Bio Therapeutics and AnTolRx Inc.
Dr. Quintana is the recipient of the Lady Anne Chain Prize for Academic Excellence and Scientific Achievements, the Junior Investigator Award from the National Multiple Sclerosis Society, the Pathway to Independence Award of the National Institute of Allergy and Infectious Diseases, the Award for Outstanding Research Achievement form Nature Biotechnology and the Tecan Award for Innovation, the Harry Weaver Award from the National Multiple Sclerosis Society.
Dr. Quintana’s research is funded through grants from the National Institutes of Health, the National Multiple Sclerosis Society, Juvenile Diabetes Research Foundation, the American Cancer Society and other foundations and industry. Dr. Quintana is a permanent member of study sections at the National Institutes of Health, the National Multiple Sclerosis Society and the Welcome Trust Peer Review College (UK).
Dr. Quintana is also the Director of the Autoimmunity Course at Harvard Medical School, his mentoring work has been recently recognized with the Harvard School of Medicine Mentor Award.